发明申请
US20100087370A1 MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
审中-公开
硝酸氧化酶信号调节为正常肿瘤血管
- 专利标题: MODULATION OF NITRIC OXIDE SIGNALING TO NORMALIZE TUMOR VASCULATURE
- 专利标题(中): 硝酸氧化酶信号调节为正常肿瘤血管
-
申请号: US12525186申请日: 2008-02-14
-
公开(公告)号: US20100087370A1公开(公告)日: 2010-04-08
- 发明人: Rakesh K. Jain , Dai Fukumura , Satoshi Kashiwagi
- 申请人: Rakesh K. Jain , Dai Fukumura , Satoshi Kashiwagi
- 申请人地址: US MA Boston
- 专利权人: THE GENERAL HOSPITAL CORPORATION
- 当前专利权人: THE GENERAL HOSPITAL CORPORATION
- 当前专利权人地址: US MA Boston
- 国际申请: PCT/US08/02004 WO 20080214
- 主分类号: A61K38/18
- IPC分类号: A61K38/18 ; A61K31/7088 ; A61P35/00
摘要:
The instant invention provides methods for treating a solid tumor in a subject comprising modulating nitric oxide production in the tumor to normalize tumor vasculature and administering an anti-tumor therapy to the subject. The invention further provides methods of treating a solid tumor in a subject comprising selectively increasing cyclic guanosine monophosphate (cGMP) or cGMP dependent protein kinase G production in the tumor vasculature to an amount effective to normalize tumor vasculature and administering an anti-tumor therapy to the subject.
信息查询
IPC分类: